SOME EFFECTS OF MAZINDOL, AN ANORECTIC DRUG, ON RAT-BRAIN MONOAMINERGIC SYSTEMS

被引：20

作者：

SUGRUE, MF ^{[1
]}

SHAW, G ^{[1
]}

CHARLTON, KG ^{[1
]}

机构：

[1] ORGANON LABS LTD,DEPT PHARMACOL,ORGANON SCI DEV GRP,NEWHOUSE ML1 5SH,LANARKSHIRE,SCOTLAND

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1977年 / 42卷 / 04期

关键词：

D O I：

10.1016/0014-2999(77)90172-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：379 / 385

页数：7

共 33 条

[11]

FIBIGER HC, 1973, BRAIN RES, V55, P135, DOI 10.1016/0006-8993(73)90493-9

[12] EFFECTS OF QUIPAZINE ON SEROTONIN METABOLISM IN RAT-BRAIN [J].

FULLER, RW ;

SNODDY, HD ;

PERRY, KW ;

ROUSH, BW ;

MOLLOY, BB ;

BYMASTER, FP ;

WONG, DT .

LIFE SCIENCES, 1976, 18 (09) :925-934

[13] IS 5-HYDROXYTRYPTAMINE INVOLVED IN MECHANISM OF ACTION OF FENFLURAMINE [J].

FUNDERBURK, WH ;

HAZELWOOD, JC ;

RUCKART, RT ;

WARD, JW .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (06) :468-+

[14]

GARATTINI S, 1975, RECENT ADV OBESITY R, V1, P354

[15] REGIONAL STUDIES OF CATECHOLAMINES IN RAT BRAIN .I. DISPOSITION OF [3H]NOREPINEPHRINE [3H]DOPAMINE AND [3H]DOPA IN VARIOUS REGIONS OF BRAIN [J].

GLOWINSKI, J ;

IVERSEN, LL .

JOURNAL OF NEUROCHEMISTRY, 1966, 13 (08) :655-+

[16]

GOGERTY JH, 1975, ARCH INT PHARMACOD T, V214, P285

[17] COMPARISON OF A NEW ANORECTIC AGENT AN 448 WITH FENFLURAMINE IN TREATMENT OF REFRACTORY OBESITY [J].

GOLDRICK, RB ;

NESTEL, PJ ;

HAVENSTEIN, N .

MEDICAL JOURNAL OF AUSTRALIA, 1974, 1 (22) :882-885

[18]

Goldstein A, 1964, BIOSTATISTICS INTRO

[19]

HESS SM, 1959, J PHARMACOL EXP THER, V127, P175

[20]

JONSSON G, 1972, RES COMMUN CHEM PATH, V3, P543

← 1 2 3 4 →